Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma - Related Studies

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

This study is currently recruiting participants.

Study NCT00033293. Last updated on November 21, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neuroblastoma

2	Additional conditions recognized in this trial
		Opsoclonus-Myoclonus Syndrome

3	More general conditions related to this trial
		Central Nervous System Diseases
		Cranial Nerve Diseases
		Dyskinesias
		Eye Diseases
		Myoclonus
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Nervous System Neoplasms
		Neurodegenerative Diseases
		Neuroectodermal Tumors
		Neuroectodermal Tumors, Primitive
		Neuroectodermal Tumors, Primitive, Peripheral
		Neurologic Manifestations
		Ocular Motility Disorders
		Paraneoplastic Syndromes
		Paraneoplastic Syndromes, Nervous System

4	Interventions listed in this trial
		therapeutic immune globulin
		observation

5	Additional drug interventions recognized in this trial
		Immunoglobulins
		Immunoglobulins, Intravenous
		Rho(D) Immune Globulin

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Children's Oncology Group
		National Cancer Institute (NCI)